Dyadic International Inc
Veridion Score
Composite trend over time
Why is DYAI moving today?
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for DYAI.
DYAI insider activity
Dyadic International Inc
No multi-insider buying cluster in the last 90 days
Net buying: $25K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2025-08-05 | 2025-08-01 | Hazelton Joseph P | Insider | buy | $0.95 | 26,000 | 155,340 | $25K | SEC Form 4 |
DYAI contract awards, year to date.
Public federal awards linked to this ticker.
DYAI lobbying filings, year to date.
Registered lobbying filings matched to Dyadic International Inc.